Neuromodulator treatments
Search documents
IMCAS 2026: Galderma Showcases the Latest Scientific Advances Behind the Industry's Broadest Injectable Aesthetics Portfolio
Businesswire· 2026-01-22 06:00
ZUG, Switzerland--(BUSINESS WIRE)--Galderma (SIX: GALD) will present ten posters with the latest updates from across its broad aesthetic portfolio spanning regenerative biostimulation, HA and neuromodulator treatments at the International Master Course on Aging Science (IMCAS) 2026 World Congress in Paris, France, from January 29-31, 2026. The company will also showcase its leadership in community education through a number of events including two symposia, a live anatomy workshop, multiple mas. ...